BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18052724)

  • 1. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
    Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
    J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model.
    Wang X; Fujita M; Prado R; Tousson A; Hsu HC; Schottelius A; Kelly DR; Yang PA; Wu Q; Chen J; Xu H; Elmets CA; Mountz JD; Edwards CK
    Br J Dermatol; 2010 Mar; 162(3):487-96. PubMed ID: 19832835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients.
    Yu K; Chen Z; Khatri I; Gorczynski RM
    Immunol Lett; 2011 Dec; 141(1):116-22. PubMed ID: 21945175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
    Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin.
    Matsui K; Nishikawa A
    J Investig Allergol Clin Immunol; 2011; 21(5):354-62. PubMed ID: 21905498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
    Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
    Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
    Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
    J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
    Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
    Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
    Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
    Scheu S; Ali S; Ruland C; Arolt V; Alferink J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of CCR4 exacerbates skin inflammation in an oxazolone-induced contact hypersensitivity model.
    Lehtimäki S; Tillander S; Puustinen A; Matikainen S; Nyman T; Fyhrquist N; Savinko T; Majuri ML; Wolff H; Alenius H; Lauerma A
    J Invest Dermatol; 2010 Dec; 130(12):2743-51. PubMed ID: 20631725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.
    Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M
    Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
    Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
    PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CCR4 antagonist ameliorates atopic dermatitis-like skin lesions induced by dibutyl phthalate and a hydrogel patch containing ovalbumin.
    Matsuo K; Hatanaka S; Kimura Y; Hara Y; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Kabashima K; Nakayama T
    Biomed Pharmacother; 2019 Jan; 109():1437-1444. PubMed ID: 30551395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
    Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
    Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus.
    Wenzel J; Henze S; Wörenkämper E; Basner-Tschakarjan E; Sokolowska-Wojdylo M; Steitz J; Bieber T; Tüting T
    J Invest Dermatol; 2005 Jun; 124(6):1241-8. PubMed ID: 15955100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines.
    Kondo T; Takiguchi M
    Int Immunol; 2009 May; 21(5):523-32. PubMed ID: 19261691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
    Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
    Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
    Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
    Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.